130 related articles for article (PubMed ID: 16103683)
1. Quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA): comparison of normative reference data for the general population of England and Wales with results for adult hypopituitary patients with growth hormone deficiency.
Kołtowska-Haggstrom M; Hennessy S; Mattsson AF; Monson JP; Kind P
Horm Res; 2005; 64(1):46-54. PubMed ID: 16103683
[TBL] [Abstract][Full Text] [Related]
2. Prediction of improvement in quality of life (QoL-AGHDA) in adults with growth hormone deficiency by normative reference limits: data of the German KIMS cohort.
Moock J; Friedrich N; Völzke H; Spielhagen C; Nauck M; Koltowska-Häggström M; Buchfelder M; Wallaschofski H; Kohlmann T
Growth Horm IGF Res; 2011 Oct; 21(5):272-8. PubMed ID: 21865066
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Japanese version of the Quality of Life-Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA).
Suzukamo Y; Noguchi H; Takahashi N; Shimatsu A; Chihara K; Green J; Fukuhara S
Growth Horm IGF Res; 2006; 16(5-6):340-7. PubMed ID: 17081792
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life and IGF-1 in GH-deficient adult patients on GH replacement therapy: analysis of the German KIMS data and the Study of Health in Pomerania.
Moock J; Albrecht C; Friedrich N; Völzke H; Nauck M; Koltowska-Haggström M; Kohlmann T; Wallaschofski H
Eur J Endocrinol; 2009 Jan; 160(1):17-24. PubMed ID: 18974232
[TBL] [Abstract][Full Text] [Related]
5. Using EQ-5D to derive general population-based utilities for the quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA).
Kołtowska-Häggström M; Jonsson B; Isacson D; Bingefors K
Value Health; 2007; 10(1):73-81. PubMed ID: 17261118
[TBL] [Abstract][Full Text] [Related]
6. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
[TBL] [Abstract][Full Text] [Related]
7. Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?
Koltowska-Häggström M; Mattsson AF; Monson JP; Kind P; Badia X; Casanueva FF; Busschbach J; Koppeschaar HP; Johannsson G
Eur J Endocrinol; 2006 Jul; 155(1):109-19. PubMed ID: 16793956
[TBL] [Abstract][Full Text] [Related]
8. Application of the disease-specific Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) questionnaire in a general population: results from a French panel study.
Gilet H; Chachuat A; Viala-Danten M; Auzière S; Koltowska-Häggström M
Value Health; 2010; 13(4):495-500. PubMed ID: 20102556
[TBL] [Abstract][Full Text] [Related]
9. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
[TBL] [Abstract][Full Text] [Related]
10. Measurements of quality of life in patients with growth hormone deficiency.
Webb SM
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):52-5. PubMed ID: 19020387
[TBL] [Abstract][Full Text] [Related]
11. The "quality of life-assessment of growth hormone deficiency in adults" questionnaire: can it be used to assess quality of life in hypopituitarism?
Barkan AL
J Clin Endocrinol Metab; 2001 May; 86(5):1905-7. PubMed ID: 11344182
[TBL] [Abstract][Full Text] [Related]
12. Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption.
Svensson J; Mattsson A; Rosén T; Wirén L; Johannsson G; Bengtsson BA; Koltowska Häggström M;
Growth Horm IGF Res; 2004 Jun; 14(3):207-15. PubMed ID: 15125882
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone (GH) replacement in hypopituitary adults with GH deficiency evaluated by a utility-weighted quality of life index: a precursor to cost-utility analysis.
Kołtowska-Häggström M; Kind P; Monson JP; Jonsson B
Clin Endocrinol (Oxf); 2008 Jan; 68(1):122-9. PubMed ID: 17803700
[TBL] [Abstract][Full Text] [Related]
14. Application of a disease-specific, quality-of-life measure (QoL-AGHDA) in growth hormone-deficient adults and a random population sample in Sweden: validation of the measure by rasch analysis.
Wirén L; Whalley D; McKenna S; Wilhelmsen L
Clin Endocrinol (Oxf); 2000 Feb; 52(2):143-52. PubMed ID: 10671940
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone deficient patients after traumatic brain injury--baseline characteristics and benefits after growth hormone replacement--an analysis of the German KIMS database.
Kreitschmann-Andermahr I; Poll EM; Reineke A; Gilsbach JM; Brabant G; Buchfelder M; Fassbender W; Faust M; Kann PH; Wallaschofski H
Growth Horm IGF Res; 2008 Dec; 18(6):472-8. PubMed ID: 18829359
[TBL] [Abstract][Full Text] [Related]
16. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
17. Influences on quality of life in GH deficient adults and their effect on response to treatment.
Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
[TBL] [Abstract][Full Text] [Related]
18. Quality of life and growth hormone deficiency in adult patients in clinical evaluation and health economic assessment.
Kołtowska-Häggström M
Pediatr Endocrinol Diabetes Metab; 2009; 15(3):203-9. PubMed ID: 20384183
[TBL] [Abstract][Full Text] [Related]
19. Quality of life in transition phase in adolescents and young adults with severe and partial growth hormone deficiency.
Oswiecimska JM; Roczniak W; Romanowicz D; Szymlak A; Mikolajczak A; Malczyk Z; Stojewska M; Ziora KT
Neuro Endocrinol Lett; 2014; 35(8):676-83. PubMed ID: 25702295
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.
Svensson J; Finer N; Bouloux P; Bevan J; Jonsson B; Mattsson AF; Lundberg M; Harris PE; Koltowska-Häggström M; Monson JP;
Growth Horm IGF Res; 2007 Feb; 17(1):67-76. PubMed ID: 17223598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
